Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE
Authors
Keywords
Mesenchymal stem cells, Toll-like receptors 3 and 4, Experimental autoimmune encephalomyelitis, Autoimmunity, Immunomodulation
Journal
Stem Cell Research & Therapy
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-10-10
DOI
10.1186/s13287-016-0402-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Toll-like receptor 3 pre-conditioning increases the therapeutic efficacy of umbilical cord mesenchymal stromal cells in a dextran sulfate sodium–induced colitis model
- (2016) Patricia Fuenzalida et al. CYTOTHERAPY
- Intravenous Administration of Bone Marrow-Derived Mesenchymal Stem Cells Induces a Switch from Classical to Atypical Symptoms in Experimental Autoimmune Encephalomyelitis
- (2015) Mónica Kurte et al. Stem Cells International
- Th17 cells in inflammation and autoimmunity
- (2014) Ram Pyare Singh et al. AUTOIMMUNITY REVIEWS
- Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE)
- (2013) Forouzan Yousefi et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses
- (2013) Qian-Qian Chen WORLD JOURNAL OF GASTROENTEROLOGY
- Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells
- (2013) Patricia Luz-Crawford et al. Stem Cell Research & Therapy
- Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications
- (2012) TacGhee Yi et al. ARCHIVES OF PHARMACAL RESEARCH
- Mesenchymal Stem Cell treatment for autoimmune diseases: a critical review
- (2012) Fernando E Figueroa et al. BIOLOGICAL RESEARCH
- Mesenchymal Stem Cells Repress Th17 Molecular Program through the PD-1 Pathway
- (2012) Patricia Luz-Crawford et al. PLoS One
- Mesenchymal Stem Cell 1 (MSC1)-Based Therapy Attenuates Tumor Growth Whereas MSC2-Treatment Promotes Tumor Growth and Metastasis
- (2012) Ruth S. Waterman et al. PLoS One
- Anti-Inflammatory Mesenchymal Stem Cells (MSC2) Attenuate Symptoms of Painful Diabetic Peripheral Neuropathy
- (2012) Ruth S. Waterman et al. Stem Cells Translational Medicine
- Immunomodulatory properties and therapeutic application of mesenchymal stem cells
- (2011) M. Shi et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Interpretation of cellular proliferation data: Avoid the panglossian
- (2011) Mario Roederer CYTOMETRY PART A
- Mesenchymal stem cell effects on T-cell effector pathways
- (2011) Michelle M Duffy et al. Stem Cell Research & Therapy
- Stem cells in the treatment of inflammatory arthritis
- (2010) Alan Tyndall et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation
- (2010) Flavio Carrión et al. IMMUNOLOGY LETTERS
- A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype
- (2010) Ruth S. Waterman et al. PLoS One
- Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis
- (2009) Lianhua Bai et al. GLIA
- Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis
- (2009) E Gonzalez-Rey et al. GUT
- Allogeneic Mesenchymal Stem Cells for Treatment of Experimental Autoimmune Encephalomyelitis
- (2009) Moutih Rafei et al. MOLECULAR THERAPY
- Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases
- (2009) Farida Djouad et al. Nature Reviews Rheumatology
- Toll-Like Receptor Engagement Enhances the Immunosuppressive Properties of Human Bone Marrow-Derived Mesenchymal Stem Cells by Inducing Indoleamine-2,3-dioxygenase-1 via Interferon-β and Protein Kinase R
- (2009) Christiane A. Opitz et al. STEM CELLS
- Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide
- (2008) Guangwen Ren et al. Cell Stem Cell
- Adipose-Derived Mesenchymal Stem Cells Alleviate Experimental Colitis by Inhibiting Inflammatory and Autoimmune Responses
- (2008) Manuel A. González et al. GASTROENTEROLOGY
- Toll-Like Receptors 3 and 4 Are Expressed by Human Bone Marrow-Derived Mesenchymal Stem Cells and Can Inhibit Their T-Cell Modulatory Activity by Impairing Notch Signaling
- (2007) Francesco Liotta et al. STEM CELLS
- Toll-Like Receptors on Human Mesenchymal Stem Cells Drive Their Migration and Immunomodulating Responses
- (2007) Suzanne L. Tomchuck et al. STEM CELLS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now